Recognition and Management of Metabolic Acidosis
Initial Recognition and Diagnostic Approach
Metabolic acidosis is confirmed by arterial blood gas showing pH <7.35 with serum bicarbonate <22 mmol/L, and you must immediately obtain a complete metabolic panel with calculated anion gap, serum lactate, serum ketones, plasma glucose, BUN/creatinine, and electrocardiogram. 1
Essential Laboratory Evaluation
- Arterial blood gas (ABG) confirms pH <7.35, measures PaCO₂ to assess respiratory compensation, and determines PaO₂; venous pH (typically ~0.03 units lower than arterial) can be used for ongoing monitoring after diagnosis is established. 1, 2
- Serum bicarbonate from basic metabolic panel is typically <22 mmol/L in metabolic acidosis, with severe acidosis showing levels <15 mmol/L. 1
- Calculate the anion gap using [Na⁺] - ([HCO₃⁻] + [Cl⁻]) to differentiate high anion gap (>12 mEq/L) from normal anion gap acidosis—this is the critical first step in determining etiology. 1, 2
Identifying the Underlying Cause
- For high anion gap acidosis (>12 mEq/L): Check serum lactate (>2 mmol/L suggests lactic acidosis from tissue hypoperfusion, sepsis, or shock), serum ketones (β-hydroxybutyrate preferred for diabetic or alcoholic ketoacidosis), and plasma glucose (>250 mg/dL with ketones suggests DKA). 1
- For normal anion gap acidosis: Consider bicarbonate loss (diarrhea, renal tubular acidosis), recovery phase of DKA, or iatrogenic causes such as large-volume normal saline administration. 1, 2
- Obtain complete blood count to identify infection or hematologic abnormalities, urinalysis with urine ketones, and electrocardiogram to detect arrhythmias or hyperkalemia changes. 1
Management Strategy: Treat the Underlying Cause First
The definitive therapy for metabolic acidosis is rapid correction of the precipitating condition and restoration of adequate tissue perfusion; sodium bicarbonate should NOT be used as primary treatment when arterial pH is ≥7.15. 2, 3
Core Treatment Priorities
- Optimize ventilation BEFORE any bicarbonate therapy if there is a concurrent respiratory component, because bicarbonate generates CO₂ that can worsen intracellular acidosis if not eliminated; ensure adequate minute ventilation targeting PaCO₂ of 30-35 mmHg. 2, 3
- Restore adequate circulation through fluid resuscitation and vasopressor support in hypoperfusion states; this is more important than bicarbonate administration. 2, 3
- Address the specific cause: insulin therapy for DKA, antibiotics and source control for sepsis, dialysis for uremic acidosis, toxin removal for ingestions. 1, 2
Specific Clinical Scenarios
Diabetic Ketoacidosis (DKA)
Bicarbonate therapy is NOT indicated in DKA unless pH falls below 6.9-7.0; the cornerstone of DKA therapy is intravenous insulin combined with fluid resuscitation. 1, 2, 3
- Initial fluid resuscitation: Administer isotonic saline (0.9% NaCl) at 15-20 mL/kg/h during the first hour to restore intravascular volume and renal perfusion. 1, 2
- Insulin therapy: After confirming serum potassium >3.3 mEq/L, start continuous IV regular insulin at 0.1 U/kg/h; when plasma glucose reaches ~250 mg/dL, reduce insulin to 0.05-0.1 U/kg/h and add 5-10% dextrose to IV fluids. 2
- Potassium replacement: Add 20-30 mEq/L potassium (2/3 KCl and 1/3 KPO₄) to maintenance fluids once urine output is established, because insulin and alkalinization drive potassium intracellularly. 1, 2
- If pH <6.9: Give 100 mmol sodium bicarbonate in 400 mL sterile water at 200 mL/h; if pH 6.9-7.0, give 50 mmol in 200 mL sterile water at 200 mL/h. 2, 3
- Resolution criteria: Glucose <200 mg/dL, serum bicarbonate ≥18 mEq/L, and venous pH ≥7.3. 2
Sepsis-Related Lactic Acidosis
Do NOT administer sodium bicarbonate for hypoperfusion-induced lactic acidemia when pH ≥7.15; two blinded randomized controlled trials showed no hemodynamic benefit and identified harms including sodium/fluid overload, increased lactate production, higher PaCO₂, and reduced ionized calcium. 2, 3
- Focus on aggressive fluid resuscitation with isotonic crystalloids, vasopressor support to maintain adequate perfusion pressure, and source control (antibiotics, drainage of abscesses). 2, 3
- If pH <7.15: Bicarbonate may be considered only after ensuring adequate ventilation and optimizing hemodynamics, but evidence for benefit is lacking even at this threshold. 2, 3
Chronic Kidney Disease (CKD)
Maintain serum bicarbonate ≥22 mmol/L with oral sodium bicarbonate 2-4 g/day (25-50 mEq/day) divided into 2-3 doses to prevent protein catabolism, bone disease, and slow CKD progression. 1, 2, 3
- Bicarbonate 18-22 mmol/L: Consider oral alkali supplementation with monthly monitoring initially, then every 3-4 months once stable. 1, 2
- Bicarbonate <18 mmol/L: Initiate pharmacological treatment with oral sodium bicarbonate promptly. 1, 2
- Monitor blood pressure, serum potassium, and fluid status regularly to ensure treatment doesn't cause hypertension or hyperkalemia. 1, 2
- Dietary approach: Increasing fruit and vegetable intake provides additional benefits beyond bicarbonate supplementation alone, including reduced systolic blood pressure and potential weight loss. 2
Indications for Intravenous Sodium Bicarbonate
Sodium bicarbonate should be given intravenously ONLY in these specific situations:
- Severe metabolic acidosis with arterial pH <7.1 AND base excess ≤-10 mmol/L after ensuring adequate ventilation is established. 2, 3
- Life-threatening hyperkalemia as a temporizing measure (1-2 mEq/kg IV) while definitive potassium-lowering therapy is initiated. 2, 3
- Tricyclic antidepressant or sodium channel blocker overdose with QRS >120 ms, targeting arterial pH 7.45-7.55 (initial bolus 50-150 mEq, then infusion of 150 mEq/L solution at 1-3 mL/kg/h). 2, 3
- Cardiac arrest only after the first epinephrine dose fails AND documented pH <7.1 (dose: 1-2 mEq/kg or 44.6-100 mEq as rapid IV bolus, repeat every 5-10 minutes guided by ABG). 2, 3
Dosing and Administration
- Initial adult dose: 1-2 mEq/kg (typically 50-100 mL of 8.4% solution) given slowly over several minutes. 2, 3
- Pediatric dose: 1-2 mEq/kg IV given slowly; for infants <2 years, use only 0.5 mEq/mL (4.2%) concentration by diluting 8.4% solution 1:1 with normal saline. 3
- Target pH: Aim for 7.2-7.3, NOT complete normalization; avoid pH >7.50-7.55. 2, 3
Critical Monitoring During Treatment
Monitor venous pH and anion gap every 2-4 hours to assess resolution of acidosis; repeat arterial blood gases are generally unnecessary after diagnosis is established. 1, 2
- Serum potassium every 2-4 hours is crucial because correction of acidosis drives potassium intracellularly and can precipitate life-threatening hypokalemia. 1, 2
- Serum electrolytes (Na⁺, Cl⁻, ionized Ca²⁺) every 2-4 hours during active bicarbonate therapy; discontinue if sodium exceeds 150-155 mEq/L. 2, 3
- Serial glucose monitoring in DKA patients to guide insulin and dextrose adjustments. 1, 2
Common Pitfalls and How to Avoid Them
- Never give bicarbonate without first ensuring adequate ventilation—bicarbonate produces CO₂ that must be eliminated to prevent paradoxical intracellular acidosis. 2, 3
- Do not treat pH ≥7.15 in lactic or septic acidosis with bicarbonate—strong evidence shows no benefit and possible harm. 2, 3
- Do not ignore potassium levels—always confirm K⁺ >3.3 mEq/L before starting bicarbonate and replace aggressively during treatment. 1, 2, 3
- Avoid large-volume 0.9% saline—this can cause iatrogenic hyperchloremic metabolic acidosis; switch to balanced crystalloids (Lactated Ringer's or Plasma-Lyte) after initial resuscitation. 2
- Never mix sodium bicarbonate with calcium-containing solutions or vasoactive amines—this causes precipitation or inactivation of catecholamines; flush the IV line with normal saline before and after bicarbonate. 3
- Bicarbonate does not replace definitive therapy—it merely buys time while the underlying cause is corrected. 2, 3
When to Hospitalize
Hospitalization is required for:
- Severe metabolic acidosis (bicarbonate <18 mmol/L or pH <7.2) requiring close monitoring and potential ICU-level care. 2
- Acute illness or catabolic state such as sepsis, DKA, or acute kidney injury superimposed on CKD. 2
- Symptomatic complications including altered mental status, severe muscle weakness, or inability to maintain oral intake. 2
- Life-threatening electrolyte disturbances such as hyperkalemia or severe hypocalcemia. 2
- Need for renal replacement therapy in refractory acidosis with pH <7.2 despite optimal medical management. 2